why choose us

Clinical Trials Search

Showing 19,170 of 132,963 result(s)
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Status: Completed

Condition: Lupus Nephritis

Interventions: KYV-101 anti-CD19 CAR-T cell therapy

Date: 2022-10-11

A Preliminary Study for INFORMED

Status: Completed

Condition: Heart Failure

Interventions:

The intervention is a two-arm crossover withdrawal;reversal design (On [A] vs Off [B]) with up to 6 periods, each period lasting up to 6 weeks

Date: 2022-10-11

Expanding Medication-Assisted Therapies in Central Asia

Status: Completed

Condition: Opioid Use Disorder

Interventions: For each country, the learning collaborative will be comprised of a Chief Narcologist from each region where the investigators will initially train th

Date: 2022-10-10

The Process of Blood Collection With a Vascular Imaging Device

Status: Completed

Condition: Phlebotomy

Interventions: Device: The phlebotomy procedure
The process of blood collection with a vascular imaging device

Date: 2022-10-10

Autologous Hair Follicle Derived Mesenchymal Stem Cell Suspension to Treat AGA

Status: Completed

Condition: Hair Transplantation

Interventions: Interventional

Date: 2022-10-10

A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada

Status: Completed

Condition: Cytomegalovirus (CMV)

Interventions:

Date: 2022-10-10

Effects of Time-restricted Eating Supported by Mobile Technology in Patients With Non-alcoholic Fatty Liver Disease: Randomized Controlled Trial

Status: COMPLETED

Condition: Non-Alcoholic Fatty Liver Disease

Interventions: Mobile application-supported nutritional counseling includes education, monitoring, interaction, and physical activity

Date: 2022-10-10

Spinal Muscular Atrophy on Wheels, Using Power Mobility

Status: Completed

Condition: Spinal Muscular Atrophy

Interventions:

Sessions of adjustment, adaptation and choice of the device for training will be carried out.
Once the cars are fully adapted and conditioned

Date: 2022-10-10

Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

Status: Completed

Condition: Double-Expressor Lymphoma

Interventions: Given IV

Date: 2022-10-10

Treatment for Migraine and Mood RCT

Status: Completed

Condition: Migraine

Interventions: Classes follow MBCT protocol delivered via telephone by a master's level or higher mental health provider under the supervision of a licensed cli

Date: 2022-10-10